Crinetics Pharmaceuticals Inc (CRNX)
57.03
+0.96
(+1.71%)
USD |
NASDAQ |
Nov 21, 16:00
57.00
-0.03
(-0.05%)
After-Hours: 20:00
Crinetics Pharmaceuticals Total Assets (Quarterly): 937.37M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 937.37M |
June 30, 2024 | 935.54M |
March 31, 2024 | 978.15M |
December 31, 2023 | 635.35M |
September 30, 2023 | 641.54M |
June 30, 2023 | 293.25M |
March 31, 2023 | 314.01M |
December 31, 2022 | 352.18M |
September 30, 2022 | 384.88M |
June 30, 2022 | 421.73M |
March 31, 2022 | 333.29M |
December 31, 2021 | 351.02M |
September 30, 2021 | 209.36M |
June 30, 2021 | 216.93M |
Date | Value |
---|---|
March 31, 2021 | 163.55M |
December 31, 2020 | 183.44M |
September 30, 2020 | 200.32M |
June 30, 2020 | 217.12M |
March 31, 2020 | 123.88M |
December 31, 2019 | 130.38M |
September 30, 2019 | 142.51M |
June 30, 2019 | 155.15M |
March 31, 2019 | 166.76M |
December 31, 2018 | 171.42M |
September 30, 2018 | 176.68M |
June 30, 2018 | 74.70M |
March 31, 2018 | 76.33M |
December 31, 2017 | 15.60M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
123.88M
Minimum
Mar 2020
978.15M
Maximum
Mar 2024
401.16M
Average
323.65M
Median
Total Assets (Quarterly) Benchmarks
Clearside Biomedical Inc | 29.16M |
Biomea Fusion Inc | 110.42M |
NovaBay Pharmaceuticals Inc | 3.877M |
Palatin Technologies Inc | 3.415M |
iBio Inc | 24.52M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 104.39M |
Shareholders Equity (Quarterly) | 832.98M |